> Skip repeated content
Studies of Immune Deregulation in Patients with SLE
Can Body Composition Help us Better Understand Outcomes in People with Lupus?
Do SLE Patients have more Early Adverse Events within 6 Months of THR and TKR?
Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis: a Randomized, Controlled Phase 2 Open Label Multicenter Study
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) (ILLUMINATE-2)
PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE)
Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients with and without Systemic Lupus Erythematosus
Autoimmune Disease Registry and Repository
Fc Receptor Function in Normals and Systemic Lupus Erythematosus (SLE)
Need Help Finding a Physician?
Call us toll-free at:
Online request form
See all Conditions & Treatments